Your browser doesn't support javascript.

Biblioteca Virtual em Saúde

Brasil

Home > Pesquisa > ()
Imprimir Exportar

Formato de exportação:

Exportar

Email
Adicionar mais destinatários
| |

The CD200 receptor is a novel and potent regulator of murine and human mast cell function.

Cherwinski, Holly M; Murphy, Craig A; Joyce, Barbara L; Bigler, Mike E; Song, Yaoli S; Zurawski, Sandra M; Moshrefi, Mehrdad M; Gorman, Daniel M; Miller, Kathy L; Zhang, Shuli; Sedgwick, Jonathan D; Phillips, Joseph H.
J Immunol; 174(3): 1348-56, 2005 Feb 01.
Artigo em Inglês | MEDLINE | ID: mdl-15661892
CD200R is a member of the Ig supergene family that is primarily expressed on myeloid cells. Recent in vivo studies have suggested that CD200R is an inhibitory receptor capable of regulating the activation threshold of inflammatory immune responses. Here we provide definitive evidence that CD200R is expressed on mouse and human mast cells and that engagement of CD200R by agonist Abs or ligand results in a potent inhibition of mast cell degranulation and cytokine secretion responses. CD200R-mediated inhibition of FcepsilonRI activation was observed both in vitro and in vivo and did not require the coligation of CD200R to FcepsilonRI. Unlike the majority of myeloid inhibitory receptors, CD200R does not contain a phosphatase recruiting inhibitory motif (ITIM); therefore, we conclude that CD200R represents a novel and potent inhibitory receptor that can be targeted in vivo to regulate mast cell-dependent pathologies.
Selo DaSilva